Atlas Trials

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Clinical trial NCT06121557 · RECRUITING

Trial details

NCT number
NCT06121557
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2023-11-01
Primary completion
2026-12-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.